Navigation Links
Vermillion to Present at the Roth 22nd Annual OC Growth Stock Conference March 15 - 17, Laguna Niguel, CA
Date:3/11/2010

FREMONT, Calif., March 11 /PRNewswire-FirstCall/ -- Vermillion, Inc (Pink Sheets: VRML) today announced that Gail Page, Vermillion's Chief Executive Officer, will be presenting at the Roth 22nd Annual OC Growth Stock Conference in Laguna Niguel.

The presentation is scheduled for Monday, March 15, 2010 at 2:00 p.m. Pacific.  The presentation will be web cast and is available through the investor relations section of our web site at www.vermillion.com.

About the OVA1 Test

The OVA1 Test is a qualitative serum test that combines the results of five immunoassays into a single numerical score. It is indicated for women who meet the following criteria: over age 18, ovarian adnexal mass present for which surgery is planned, and not yet referred to an oncologist. The test utilizes five well-established biomarkers --- Transthyretin (TT or prealbumin), Apolipoprotein A-1 (Apo A-1), Beta2-Microglobulin (Beta2M), Transferrin (Tfr) and Cancer Antigen 125 (CA 125 II) --  and a proprietary algorithm to determine the likelihood of malignancy in women with pelvic mass for whom surgery is planned.

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at http://www.vermillion.com.

SOURCE Vermillion, Inc.

Back to top

RELATED LINKS
http://www.vermillion.com

'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vermillion Adds Peter S. Roddy to Board and Provides Corporate Update
2. Vermillion Announces the Reappointment of Officers and Confirmation of Director
3. Vermillion Announces $43.05 Million Private Placement of Common Stock
4. Vermillion Files Amended Plan of Reorganization and Exchanges Debt
5. Vermillion Files Plan of Reorganization
6. Vermillion to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
7. Vermillion Presents Critical Data From Its OVA1 Clinical Trial
8. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
9. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
10. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
11. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... March 29, 2017 Varian Medical Systems (NYSE: ... for the second quarter of fiscal year 2017 following the ... news release will be followed by a teleconference available to ... and a link to the conference call webcast will be ... access the teleconference call and replay: ...
(Date:3/29/2017)... , March 29, 2017   Royal Philips ... in health technology, and PathAI, a company that ... with the aim to develop solutions that improve ... cancer and other diseases. The partnership aims to ... this form of artificial intelligence to be applied ...
(Date:3/29/2017)... TEL AVIV, Israel , March 29, 2017 ... license agreement in which Exeltis will obtain exclusive marketing rights for ... ... is an age-appropriate drug targeted to treat sleep disorders in children ... to be the first sleep medication approved for children. ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 29, 2017 , ... Altima Technologies, Inc., the maker of ... center assets and audio-video devices has recently updated its Visio Stencils library with ... and download shapes and stencils from http://www.VisioStencils.com. , New devices were ...
(Date:3/29/2017)... ... 29, 2017 , ... HealthCareMandA.com will host an important webinar — Home Health ... ET. A recording of the webinar will also be made available following its live ... hospice companies are still popular targets for healthcare investors. This highly fragmented sector bounced ...
(Date:3/29/2017)... ... , ... Hamlin Dental Group, multi-location dental office in North Hollywood , ... are safe and effective options, and can be used alone or in conjunction with ... of care. , Dr. Hamid Reza of Hamlin Dental Group offers other treatments as ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of the University of ... W’81, have made a $10 million gift to establish the Ken Moelis and ... a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career ...
(Date:3/28/2017)... ... March 28, 2017 , ... A recent Bellwether Education Partners’ ... the field must first improve teacher preparation program design. It then asserts that ... that decades of input- and outcome-based research has failed to improve teacher education. ...
Breaking Medicine News(10 mins):